|
Market Closed -
Bombay S.E.
06:02:28 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 596.10 INR | -4.19% |
|
-8.90% | +35.94% |
| 08-14 | Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 05-30 | Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026 | CI |
| Market Cap | 1.32B 13.94M 12.03M 11.31M 10.32M 19.38M 19.5M 134M 52.13M 673M 52.35M 51.21M 2.23B | P/E 2024 |
8.4x | P/E 2025 | 10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.05B 11.06M 9.54M 8.97M 8.18M 15.37M 15.47M 106M 41.34M 534M 41.52M 40.62M 1.77B | EV / Sales 2024 |
1.25x | EV / Sales 2025 | 1.94x |
| Free-Float |
19.97% | Yield 2024 |
0.54% | Yield 2025 | 0.21% |
| 1 day | -4.19% | ||
| 1 week | -8.90% | ||
| Current month | -4.19% | ||
| 1 month | +3.79% | ||
| 3 months | +26.01% | ||
| 6 months | +34.35% | ||
| Current year | +35.94% |
| 1 week | 592.4 |  | 663.2 |
| 1 month | 540 | | 679 |
| Current year | 360 | | 679 |
| 1 year | 360 | | 679 |
| 3 years | 262 | | 999 |
| 5 years | 217 | | 999 |
| 10 years | 81.2 | | 1,190 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 49 | 2017-05-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 45 | 2017-05-25 | |
| Director/Board Member | 49 | 2017-05-25 | |
Saurabh Shah
BRD | Director/Board Member | 40 | 2019-05-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.19% | -8.90% | +33.65% | +118.63% | 23.36M | |
| +0.28% | -6.97% | +58.34% | +109.31% | 1,031B | |
| +2.01% | -0.68% | +53.07% | +67.73% | 641B | |
| +1.39% | -1.71% | +23.57% | +76.91% | 453B | |
| -1.50% | -6.18% | +33.50% | +33.50% | 349B | |
| +6.25% | +3.31% | +29.46% | +46.64% | 290B | |
| -0.07% | -1.22% | +1.46% | +12.19% | 252B | |
| +1.92% | -1.29% | +52.28% | +70.91% | 232B | |
| +0.51% | -1.79% | -18.09% | -53.86% | 201B | |
| +2.45% | +2.17% | +32.71% | +96.03% | 181B | |
| Average | +0.96% | -3.17% | +30.00% | +57.80% | 362.98B | |
| Weighted average by Cap. | +1.38% | -3.97% | +38.53% | +66.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 837M 8.81M 7.6M 7.15M 6.52M 12.25M 12.32M 84.66M 32.94M 425M 33.08M 32.37M 1.41B | 1.15B 12.11M 10.45M 9.82M 8.96M 16.84M 16.94M 116M 45.28M 585M 45.48M 44.49M 1.94B |
| Net income | 158M 1.66M 1.43M 1.35M 1.23M 2.31M 2.33M 15.98M 6.22M 80.29M 6.24M 6.11M 266M | 242M 2.54M 2.19M 2.06M 1.88M 3.54M 3.56M 24.45M 9.51M 123M 9.55M 9.35M 408M |
| Net Debt | -278M -2.93M -2.52M -2.37M -2.17M -4.07M -4.09M -28.12M -10.94M -141M -10.99M -10.75M -469M | -274M -2.88M -2.49M -2.34M -2.13M -4.01M -4.03M -27.72M -10.78M -139M -10.83M -10.6M -462M |
Employees
197
Sector
Pharmaceuticals
Calendar
09-22
Ex-dividend date - 2 INR
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | ₹596.10 | -4.19% | 2,363 |
| 26-08-31 | ₹622.15 | -3.27% | 1,914 |
| 26-08-28 | ₹643.15 | +0.77% | 791 |
| 26-08-27 | ₹638.25 | -1.05% | 553 |
| 26-08-26 | ₹645.00 | +0.36% | 725 |
- Stock Market
- Stocks
- CORALAB6 Stock
Select your edition
All financial news and data tailored to specific country editions
